Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Insider Filings - MAHONEY DAVID L
Last Updated 
15-May-14
Enter symbol:
symbol lookup

 

EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search

MAHONEY DAVID L: Declared Holdings
Company/RelationshipReportedShares  Ownership
Adamas Pharmaceuticals, Inc.
Director
NasdaqGM:ADMS
(historical quotes, profile, other insiders)
15-Apr-14
15-Apr-14
23,821
   2,628
26,449
  Direct
  Indirect  
  Total
Corcept Therapeutics Incorporat
Director
NasdaqCM:CORT
(historical quotes, profile, other insiders)
9-May-141,119,533  Indirect
Symantec Corporation
Director
NasdaqGS:SYMC
(historical quotes, profile, SEC, other insiders)
13-May-14137,840  Direct

Insider & restricted shareholder transactions reported over the last two years
DateSharesStockTransaction
13-May-14 11,058SYMC Acquisition (Non Open Market) at $0 per share.
9-May-14 *100,000CORT Purchase at $1.85 per share.
(Cost of $185,000)
15-Apr-14 13,147ADMS Acquisition (Non Open Market)
15-Apr-14 *2,628ADMS Acquisition (Non Open Market)
9-Apr-14 10,674ADMS Statement of Ownership
10-May-13 9,650SYMC Acquisition (Non Open Market) at $0 per share.
2-Nov-12 70,000SYMC Option Exercise at $9.91 per share.
(Cost of $693,700)
2-Nov-12 52,370SYMC Sale at $18.76 - $18.83 per share.
(Proceeds of about $984,000)

 

 

    * Indicates that some (or all) shares are held indirectly (e.g. in a trust, by a spouse, etc.)



EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Data and information are provided by EDGAR Online, Inc. for informational purposes only and not intended for trading purposes. Yahoo!, EDGAR Online, Inc. shall have no liability for the accuracy of the information furnished or for delays, omissions or opinions expressed therein. You may not use the information for any illegal purpose or furnish the information to any person, firm, or branch office for commercial re-use or re-sale.

Questions or Comments?